Topics

An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola

2020-02-19 18:28:39 | BioPortfolio

Summary

The purpose of this study is to determine how safe and tolerable Brincidofovir (BCV) is when given for post exposure prophylaxis of Ebola virus disease.

Description

The primary objective of this study is to evaluate the safety and tolerability of BCV when administered for post-exposure prophylaxis of EVD

Study Design

Conditions

EVD

Intervention

Brincidofovir

Status

Withdrawn

Source

Chimerix

Results (where available)

View Results

Links

Published on BioPortfolio: 2020-02-19T18:28:39-0500

Clinical Trials [0 Results]

None

PubMed Articles [0 Results]

None

Medical and Biotech [MESH] Definitions

None available.

More From BioPortfolio on "An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola"

Quick Search

Relevant Topic

Marburg and Ebola Virus Infections
Ebola virus and Marburg virus are related viruses that cause hemorrhagic fevers — illnesses marked by severe bleeding (hemorrhage), organ failure and, in many cases, death. Both viruses are native to Africa, where sporadic outbreaks have occurred f...


Searches Linking to this Trial